Pathway Analysis of Kidney Cancer Using Proteomics and Metabolic Profiling
Author Information
Author(s): Perroud Bertrand, Lee Jinoo, Valkova Nelly, Dhirapong Amy, Lin Pei-Yin, Fiehn Oliver, Kültz Dietmar, Weiss Robert H
Primary Institution: University of California, Davis, CA, USA
Hypothesis
This study investigates biological processes involved in clear cell renal cell carcinoma (ccRCC) through comprehensive proteomic analysis and metabolic profiling.
Conclusion
The study identifies significant pathways in ccRCC and suggests potential urinary biomarkers for early diagnosis.
Supporting Evidence
- 31 proteins were identified as differentially expressed in ccRCC compared to adjacent non-malignant tissue.
- Metabolic profiling showed that sorbitol was significantly elevated in RCC patients compared to controls.
- Pathway analysis indicated significant involvement of glycolysis and amino acid metabolism in ccRCC.
Takeaway
Researchers looked at proteins in kidney cancer samples to find out how the disease works and to discover new ways to diagnose it using urine tests.
Methodology
The study used 2-dimensional electrophoresis and mass spectrometric analysis to identify proteins in ccRCC tissue and performed metabolic profiling on urine samples.
Potential Biases
The proteomic analysis may be biased towards high abundance soluble proteins, potentially missing low abundance or membrane proteins.
Limitations
The study's findings are based on a relatively small sample size, which may affect the generalizability of the results.
Participant Demographics
The study included four patients with clear cell RCC, consisting of two males and two females aged 32 to 79 years.
Statistical Information
P-Value
< 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website